🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The Race Against Antimicrobial Resistance in Neonates: Insights on Data, Infection Prevention, and Stewardship Date: Tuesday, November 19, 2024 Africa Times: 11:30 p.m. GMT | 12:30 p.m. WAT | 1:30 p.m. CAT | 2:30 p.m. EAT Register: cdc.zoomgov.com/.../WN_tdLh5JE…...

Great discussions today with Ambassador @MayaTissafi on AMR in India and around the world. With allies like Switzerland, GARDP is strengthening its efforts to tackle this pressing global health challenge.

Public-health driven R&D and access is what we need, not just for antibiotics but for all conditions that affect children. We are happy to be part of the GAP-f network to ensure that children, particularly in low- and middle-income countries, have equitable access to medicines.

The Superbug Fight Needs a Better Business Model globalhealthnow.org/2024-11/superb…

Hear from Takuko Sawada, Director and Vice Chairperson of the Board, Shionogi & Co., Ltd. and Manica Balasegaram, Executive Director of Global Antibiotic R&D Partnership (GARDP), about how we are working together to increase access to antibiotics, as part of addressing #AMR. #WAAW shionogi.com/content/dam/sh…

It’s antibiotic awareness week! #AntimicrobialResistance (AR) kills an estimated 1 million people every year & is one of the greatest health threats we face today. To learn more about how to prevent AR, including through responsible antibiotic use, visit bit.ly/3CuWytd

Thanks Vikas Dandekar for this great discussion about India's potential influence in tackling AMR.

We're looking forward to the #Fierce50 ceremony! GARDP's Executive Director, Manica Balasegaram, has been lauded as a 2024 #Fierce50 honoree! 🎉 This recognition highlights his work in driving progress in the fight against #AMR.

Conflicts often create conditions that are perfect for emergence and spread of drug resistance, a phenomenon first documented as early as the 1940s. nytimes.com/2024/11/26/mag…

Excellent article on India’s locally developed new drugs and the game-changing solution they offer to preserve last-resort treatments. We need more innovation and to learn from past mistakes. bbc.com/news/articles/…

Yesterday our Executive Director Manica Balasegaram was in #NYC for the #Fierce50 awards gala. ✨ The #Fierce50 is a groundbreaking project that highlights the people & companies driving meaningful change in #healthcare, pharma and #biotech. Manica accepted the award for the

India could be at the forefront of the solution. With its scientific expertise, clinical resources and pharmaceutical sector, India has everything it needs to not only to tackle the AMR crisis within its borders but also to lead the way. thehindu.com/opinion/op-ed/…

Fascinating article that deserves a more in-depth unpacking. It’s also relevant considering the evolved challenges in the antibiotic space today. journals.plos.org/globalpubliche…

Very honored to accept this award as a recognition of the work of GARDP and its key partners, especially our partnership with Innoviva Speciality Therapuetics, Inc. for the development of zoliflodacin.

Policy and regulatory interventions to address antibiotic shortages in low and middle-income countries iris.who.int/bitstream/hand…

As 2024 comes to a close, I’m proud of what we’ve achieved together. None of this would have been possible without the dedication, expertise, and passion of our team. Together, we’ll keep pushing forward to deliver life-saving treatments to those who need them most.

How more than 50 million deaths could be prevented by increasing access to antibiotics 💊 Read Manica Balasegaram piece in World Economic Forum 👇 weforum.org/agenda/2024/10…

📢 #WorldNTDDay is this Thursday 30 January! This is a chance to raise awareness for the 1 billion+ people affected by neglected tropical diseases! How you can help: 1️⃣ Download our messaging materials: bit.ly/DNDiWorldNTDDa… 2️⃣ Share them on your channels this week. #BeatNTDs

Infections are the 2nd leading cause of deaths for cancer patients. Without new #antibiotics, survival rates could start to decline On this #WorldCancerDay, let’s commit to fighting #cancer & #AMR. Because survival should mean a second chance at life - not another battle for it

We’re thrilled to welcome Dr. José Gomes Temporão to GARDP’s Board! As our first Board member from #LATAC, he brings invaluable expertise to the fight against #AMR. 📢 Learn more: gardp.org/brazils-former…